BACHRODT AMY (SVP, Finance) sold 27.8% of their position (5K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $230.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.84K
Price / share
$10.42
Trade value
$50.47K
% of position
Common Stock
Shares
+156.00
Price / share
$10.42
Trade value
$1.63K
% of position
Common Stock
Shares
−200.00
Price / share
$44.15
Trade value
$8.83K
% of position
Common Stock
Shares
−4.06K
Price / share
$46.03
Trade value
$187.07K
% of position
Common Stock
Shares
−736.00
Price / share
$46.63
Trade value
$34.32K
% of position
Net shares
+0.00
Net value
-$178.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | M · Option Exercise | +4.84K | $10.42 | $50.47K | 37.4% | 12.96K | 17.81K |
| Common Stock Direct | 2/2/2026 | M · Option Exercise | +156.00 | $10.42 | $1.63K | 0.9% | 17.81K | 17.96K |
| Common Stock Direct | 2/2/2026 | S · Sale | −200.00 | $44.15 | $8.83K | 1.1% | 17.96K | 17.77K |
| Common Stock Direct | 2/2/2026 | S · Sale | −4.06K | $46.03 | $187.07K | 22.9% | 17.77K | 13.70K |
| Common Stock Direct | 2/2/2026 | S · Sale | −736.00 | $46.63 | $34.32K | 5.4% | 13.70K | 12.96K |
| Total | +0.00 | -$178.12K | ||||||
Stock Option (Right to Buy)
Common Stock
4.84K shares
Shares
−4.84K
Strike price
10.42
Held after
3.02K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
156.00 shares
Shares
−156.00
Strike price
10.42
Held after
41.33K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.84K shares | 2/2/2026 | M · Option Exercise | −4.84K | 10.42 | — | 3.02K |
| Stock Option (Right to Buy) Direct | Common Stock156.00 shares | 2/2/2026 | M · Option Exercise | −156.00 | 10.42 | — | 41.33K |